373 GENES FOUNDi
Show / hide columns XML | RDF | TSV | « prev | Page of 8 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x Prognostic p-valuei x RNA tissue categoryi x
CD207CD207 moleculeCD markers
Disease related genes
Predicted membrane proteins
CytosolTissue enriched
CD209CD209 moleculeCD markers
Predicted intracellular proteins
Predicted membrane proteins
Renal cancer: 1.15e-5
Tissue enhanced
CD22CD22 moleculeCD markers
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
CD226CD226 moleculeCD markers
Predicted membrane proteins
Predicted secreted proteins
MidbodyTissue enriched
CD244CD244 moleculeCD markers
Plasma proteins
Predicted membrane proteins
Tissue enhanced
CD247CD247 moleculeCD markers
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Endometrial cancer: 8.63e-6
Renal cancer: 9.94e-6
Head and neck cancer: 3.98e-4
Breast cancer: 9.12e-4
Tissue enhanced
CD248CD248 moleculeCD markers
Predicted membrane proteins
Nucleoplasm
Plasma membrane
Renal cancer: 2.69e-7
Tissue enhanced
CD27CD27 moleculeCancer-related genes
CD markers
Disease related genes
Plasma proteins
Predicted membrane proteins
Head and neck cancer: 6.65e-7
Renal cancer: 1.19e-6
Cervical cancer: 3.77e-5
Endometrial cancer: 2.90e-4
Melanoma: 5.50e-4
Tissue enhanced
CD274CD274 moleculeCancer-related genes
CD markers
FDA approved drug targets
Predicted membrane proteins
CytosolColorectal cancer: 1.64e-5
Breast cancer: 8.89e-4
Mixed
CD276CD276 moleculeCD markers
Predicted membrane proteins
Predicted secreted proteins
VesiclesRenal cancer: 6.31e-5
Liver cancer: 9.81e-4
Mixed
CD28CD28 moleculeCD markers
Predicted membrane proteins
Tissue enhanced
CD300ACD300a moleculeCD markers
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Renal cancer: 1.91e-5
Tissue enhanced
CD300CCD300c moleculeCD markers
Predicted membrane proteins
Testis cancer: 8.53e-5
Tissue enhanced
CD300ECD300e moleculeCD markers
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
CD300LBCD300 molecule like family member bCD markers
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
CD300LDCD300 molecule like family member dCD markers
Predicted membrane proteins
Not detected
CD300LFCD300 molecule like family member fCD markers
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
CD300LGCD300 molecule like family member gCD markers
Predicted membrane proteins
Predicted secreted proteins
Group enriched
CD302CD302 moleculeCD markers
Predicted membrane proteins
Expressed in all
CD320CD320 moleculeCD markers
Disease related genes
Predicted membrane proteins
CytosolLiver cancer: 4.02e-4
Expressed in all
CD33CD33 moleculeCD markers
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Nucleus
Plasma membrane
Tissue enhanced
CD34CD34 moleculeCD markers
Predicted membrane proteins
Nucleus
Plasma membrane
Cell Junctions
Head and neck cancer: 5.93e-5
Renal cancer: 8.47e-4
Expressed in all
CD36CD36 moleculeCancer-related genes
CD markers
Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
Golgi apparatusStomach cancer: 4.47e-4
Expressed in all
CD37CD37 moleculeCD markers
Predicted intracellular proteins
Predicted membrane proteins
Endometrial cancer: 4.51e-4
Tissue enhanced
CD38CD38 moleculeCancer-related genes
CD markers
Enzymes
Predicted intracellular proteins
Plasma membraneEndometrial cancer: 9.68e-4
Mixed
CD3DCD3d moleculeCD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Endometrial cancer: 1.73e-7
Renal cancer: 3.07e-5
Cervical cancer: 8.46e-5
Head and neck cancer: 1.70e-4
Breast cancer: 3.00e-4
Urothelial cancer: 6.16e-4
Tissue enhanced
CD3ECD3e moleculeCD markers
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Endometrial cancer: 2.30e-6
Renal cancer: 1.12e-5
Melanoma: 1.18e-4
Head and neck cancer: 1.32e-4
Cervical cancer: 1.62e-4
Breast cancer: 1.72e-4
Tissue enhanced
CD3GCD3g moleculeCD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Renal cancer: 9.33e-5
Cervical cancer: 2.61e-4
Head and neck cancer: 3.00e-4
Breast cancer: 6.33e-4
Tissue enhanced
CD4CD4 moleculeCD markers
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Plasma membraneEndometrial cancer: 2.16e-4
Renal cancer: 7.45e-4
Tissue enhanced
CD40CD40 moleculeCancer-related genes
CD markers
Disease related genes
Predicted membrane proteins
Predicted secreted proteins
Renal cancer: 4.48e-4
Expressed in all
CD40LGCD40 ligandCancer-related genes
Candidate cardiovascular disease genes
CD markers
Disease related genes
Predicted membrane proteins
Tissue enhanced
CD44CD44 molecule (Indian blood group)Blood group antigen proteins
Cancer-related genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Golgi apparatus
Plasma membrane
Renal cancer: 1.78e-8
Expressed in all
CD46CD46 moleculeCancer-related genes
CD markers
Disease related genes
Plasma proteins
Predicted membrane proteins
Plasma membraneCervical cancer: 8.54e-5
Stomach cancer: 2.38e-4
Expressed in all
CD47CD47 moleculeCD markers
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Golgi apparatus
Vesicles
Plasma membrane
Thyroid cancer: 7.29e-5
Renal cancer: 1.69e-4
Endometrial cancer: 2.44e-4
Expressed in all
CD48CD48 moleculeCD markers
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Nucleoli fibrillar center
Plasma membrane
Cytosol
Renal cancer: 3.36e-4
Breast cancer: 3.91e-4
Colorectal cancer: 4.17e-4
Tissue enhanced
CD5CD5 moleculeCD markers
Predicted membrane proteins
Predicted secreted proteins
Head and neck cancer: 7.41e-6
Renal cancer: 8.94e-5
Endometrial cancer: 9.00e-5
Cervical cancer: 9.16e-5
Melanoma: 3.93e-4
Breast cancer: 4.05e-4
Tissue enhanced
CD52CD52 moleculeCancer-related genes
CD markers
FDA approved drug targets
Predicted membrane proteins
Breast cancer: 1.85e-5
Endometrial cancer: 2.06e-4
Head and neck cancer: 4.45e-4
Renal cancer: 5.85e-4
Tissue enriched
CD53CD53 moleculeCD markers
Predicted membrane proteins
Transporters
Renal cancer: 2.60e-4
Expressed in all
CD55CD55 molecule (Cromer blood group)Blood group antigen proteins
CD markers
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Vesicles
Midbody ring
Renal cancer: 9.36e-4
Expressed in all
CD58CD58 moleculeCD markers
Predicted membrane proteins
Liver cancer: 2.32e-6
Pancreatic cancer: 5.60e-4
Expressed in all
CD59CD59 moleculeCancer-related genes
CD markers
Disease related genes
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Golgi apparatus
Vesicles
Renal cancer: 1.39e-10
Pancreatic cancer: 2.92e-5
Head and neck cancer: 3.10e-5
Cervical cancer: 3.81e-5
Stomach cancer: 9.03e-4
Expressed in all
CD6CD6 moleculeCD markers
Predicted membrane proteins
Predicted secreted proteins
Head and neck cancer: 5.10e-6
Cervical cancer: 1.57e-5
Renal cancer: 1.82e-4
Breast cancer: 1.95e-4
Endometrial cancer: 2.41e-4
Tissue enhanced
CD63CD63 moleculeCD markers
Plasma proteins
Predicted membrane proteins
Transporters
VesiclesLiver cancer: 1.37e-4
Expressed in all
CD68CD68 moleculeCD markers
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Golgi apparatus
Vesicles
Renal cancer: 1.14e-5
Expressed in all
CD69CD69 moleculeCD markers
Predicted membrane proteins
Breast cancer: 3.31e-5
Renal cancer: 7.87e-5
Tissue enhanced
CD7CD7 moleculeCD markers
Predicted membrane proteins
Predicted secreted proteins
Renal cancer: 7.75e-11
Endometrial cancer: 2.03e-5
Melanoma: 2.69e-4
Cervical cancer: 5.51e-4
Tissue enhanced
CD70CD70 moleculeCancer-related genes
CD markers
Predicted intracellular proteins
Predicted membrane proteins
NucleoplasmRenal cancer: 3.22e-4
Lung cancer: 6.29e-4
Tissue enhanced
CD72CD72 moleculeCD markers
Predicted intracellular proteins
Predicted membrane proteins
Nucleus
Mitochondria
Renal cancer: 2.49e-8
Group enriched
CD74CD74 moleculeCancer-related genes
CD markers
Disease related genes
Predicted membrane proteins
Golgi apparatusEndometrial cancer: 6.53e-6
Breast cancer: 1.06e-4
Expressed in all
CD79ACD79a moleculeCancer-related genes
CD markers
Disease related genes
Predicted membrane proteins
Predicted secreted proteins
Head and neck cancer: 1.18e-5
Renal cancer: 2.15e-5
Breast cancer: 8.45e-5
Group enriched
« prev | Page of 8 | next »